A comparison of change in the 0-10 numeric rating scale to a pain relief scale and global medication performance scale in a short-term clinical trial of breakthrough pain intensity

Anesthesiology

Volumn 112, Issue 6, 2010, Pages 1464-1472

  Farrar, John T ^a   Polomano, Rosemary C ^b   Berlin, Jesse A ^c   Strom, Brian L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^c JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL CITRATE; MORPHINE SULFATE; PLACEBO;

ADULT; ARTICLE; CANCER PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; FEMALE; GLOBAL MEDICATION PERFORMANCE SCALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PAIN ASSESSMENT; PAIN RELIEF VERBAL RESPONSE SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT OUTCOME;

EID: 77953025286     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181de0e6d     Document Type: Article

References (42)

1. Bromm B: The measurement of pain in man, Pain Measurement in Man. Edited by Bromm B. Amsterdam, Elsevier Science Publishers, 1984, pp 3-13
2. Katz J, Melzack R: Measurement of pain. Surg Clin North Am 1999; 79:231-252
3. Farrar JT, Dworkin RH, Max MB: Use of the Cumulative Proportion of Responders Analysis graph to present pain data over a range of cut-off points: Making clinical trial data more understandable. J Pain Symptom Manage 2006; 30:369-377
4. Donaldson G: Patient-reported outcomes and the mandate of measurement. Qual Life Res 2008; 17:1303-1313
5. Chapman CR, Dunbar PJ: Measurement in pain therapy: Is pain relief really the endpoint? Curr Opin Anaesthesiol 1998; 11:533-537
6. Jensen MP: Using pain quality assessment measures for selecting analgesic agents. Clin J Pain 2006; 22:S9-13
7. Jensen MP, Martin SA, Cheung R: The meaning of pain relief in a clinical trial. J Pain 2005; 6:400-406
8. Tolle T, Freynhagen R, Versavel M, Trostmann U, Young JP Jr: Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double-blind study. Eur J Pain 2008; 12:203-213
9. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S, Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S: Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008; 9:105-121
10. Turk DC, Dworkin RH, Revicki D, Harding G, Burke LB, Cella D, Cleeland CS, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Turk DC, Dworkin RH, Revicki D, Harding G, Burke LB, Cella D, Cleeland CS, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA: Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain. Pain 2008; 137: 276-285
11. Cleeland CS, Ryan KM: Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23: 129-138
12. Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Clee-land CS, Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS: Validity of the brief pain inventory for use in documenting the outcomes of patients with non-cancer pain. Clin J Pain 2004; 20:309-318
13. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM: Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94:149-158
14. Coluzzi PH, Schwartzberg L, Conroy JD, Charapata S, Gay M, Busch MA, Chavez J, Ashley J, Lebo D, McCracken M, Portenoy RK: Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 2001; 91:123-130
15. Lichtor JL, Sevarino FB, Joshi GP, Busch MA, Nordbrock E, Ginsberg B: The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain. Anesth Analg 1999; 89:732-738
16. Cepeda MS, Africano JM, Polo R, Alcala R, Carr DB: What decline in pain intensity is meaningful to patients with acute pain? Pain 2003; 105:151-157
17. Vickers AJ: The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: A simulation study. BMC Med Res Methodol 2001; 1:6
18. Berger VW, Lunneborg CE, Ernst MD, Levine JG: Parametric analyses in randomized clinical trials. J Mod Appl Stat Methods 2002; 1:74-82
19. Svensson E: Guidelines to statistical evaluation of data from rating scales and questionnaires. J Rehabil Med 2001; 33:47-48
20. Beecher HK: Measurement of Subjective Responses. New York, Oxford University Press, 1959
21. Houde RW: Methods for measuring clinical pain in humans. Acta Anaesthesiol Scand Suppl 1982; 74:25-29
22. Lasagna L: The clinical measurement of pain. Ann N Y Acad Sci 1960; 86:28-37
23. Turk DC, Rudy TE, Sorkin BA: Neglected topics in chronic pain treatment outcome studies: Determination of success. Pain 1993; 53:3-16
24. Goldsmith CH, Boers M, Bombardier C, Tugwell P: Criteria for clinically important changes in outcomes: Development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol 1993; 20:561-565
25. FDA Guidance for Industry: Clinical Development Programs for Drugs, Devices, and Biological Products for the Treatment of Rheumatoid Arthritis (RA). Rockville, MD, Food and Drug Administration, 1999
26. Moore A, McQuay H, Gavaghan D: Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain 1996; 66:229-237
27. Rowbotham MC, Reisner LA, Davies PS, Fields HL: Treatment response in antidepressant-naive postherpetic neuralgia patients: Double-blind, randomized trial. J Pain 2005; 6:741-746
28. Simpson DM, Brown S, Tobias J: Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008; 70:2305-2313
29. Wu CL, Agarwal S, Tella PK, Klick B, Clark MR, Haythorn-thwaite JA, Max MB, Raja SN: Morphine versus mexiletine for treatment of postamputation pain: A randomized, placebo-controlled, crossover trial. ANESTHESIOLOGY 2008; 109: 289-296
30. Lin PL, Fan SZ, Huang CH, Huang HH, Tsai MC, Lin CJ, Sun WZ: Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: A double-blind and vehicle-controlled study. Reg Anesth Pain Med 2008; 33:320-325
31. Moore RA, Moore OA, Derry S, McQuay HJ: Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores. Arthritis Res Ther 2008; 10:R39
32. Stacey BR, Swift JN: Pregabalin for neuropathic pain based on recent clinical trials. Curr Pain Headache Rep 2006; 10:179-184
33. Stegmann JU, Weber H, Steup A, Okamoto A, Upmalis D, Daniels S: The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery. Curr Med Res Opin 2008; 10:10
34. Sultan A, Gaskell H, Derry S, Moore RA: Duloxetine for painful diabetic neuropathy and fibromyalgia pain: Systematic review of randomised trials. BMC Neurol 2008; 8:29
35. Viscusi ER, Martin G, Hartrick CT, Singla N, Manvelian G: Forty-eight hours of postoperative pain relief after total hip arthroplasty with a novel, extended-release epidural morphine formulation. ANESTHESIOLOGY 2005; 102:1014-1022
36. Fishman B, Pasternak S, Wallenstein SL, Houde RW, Holland JC, Foley KM: The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain. Cancer 1987; 60:1151-1158
37. Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Ro-mundstad L, Hals EK, Kvarstein G, Stubhaug A: Assessment of pain. Br J Anaesth 2008; 101:17-24
38. Fishbain D: Evidence-based data on pain relief with anti-depressants. Ann Med 2000; 32:305-316
39. Aubrun F, Salvi N, Coriat P, Riou B, Aubrun F, Salvi N, Coriat P, Riou B: Sex- and age-related differences in morphine requirements for postoperative pain relief. ANESTHE-SIOLOGY 2005; 103:156-160
40. Edrington JM, Paul S, Dodd M, West C, Facione N, Tripathy D, Koo P, Schumacher K, Miaskowski C, Edrington JM, Paul S, Dodd M, West C, Facione N, Tripathy D, Koo P, Schumacher K, Miaskowski C: No evidence for sex differences in the severity and treatment of cancer pain. J Pain Symptom Manage 2004; 28:225-232
41. Hobara M, Hobara M: Beliefs about appropriate pain behavior: Cross-cultural and sex differences between Japanese and Euro-Americans. Eur J Pain 2005; 9:389-393
42. Wijnhoven HA, de Vet HC, Picavet HS, Wijnhoven HAH, de Vet HCW, Picavet HSJ: Explaining sex differences in chronic musculoskeletal pain in a general population. Pain 2006; 124:158-166